Related Experiment Video
Updated: May 6, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Genetic alterations in glioma
Linda B C Bralten1, Pim J French
1Department of Neurology, Erasmus University Medical Center, Erasmus University Rotterdam, Dr Molewaterplein 50, 3000 CA, Rotterdam, the Netherlands. p.french@erasmusmc.nl.
Abstract:
Gliomas are the most common type of primary brain tumor and have a dismal prognosis. Understanding the genetic alterations that drive glioma formation and progression may help improve patient prognosis by identification of novel treatment targets. Recently, two major studies have performed in-depth mutation analysis of glioblastomas (the most common and aggressive subtype of glioma). This systematic approach revealed three major pathways that are affected in glioblastomas: The receptor tyrosine kinase signaling pathway, the TP53 pathway and the pRB pathway. Apart from frequent mutations in the IDH1/2 gene, much less is known about the causal genetic changes of grade II and III (anaplastic) gliomas. Exceptions include TP53 mutations and fusion genes involving the BRAF gene in astrocytic and pilocytic glioma subtypes, respectively. In this review, we provide an update on all common events involved in the initiation and/or progression across the different subtypes of glioma and provide future directions for research into the genetic changes.
Insights
Understanding genetic alterations in gliomas, common brain tumors with poor outcomes, is key. Research highlights affected pathways in glioblastomas and identifies genetic changes in other glioma subtypes for new treatments.
Area of Science:
- Neuro-oncology
- Cancer Genetics
- Molecular Biology
Background:
- Gliomas are primary brain tumors with poor prognosis.
- Understanding genetic drivers is crucial for improved patient outcomes and novel therapeutic targets.
- Recent studies analyzed glioblastoma (GBM) mutations, revealing key affected pathways.
Purpose of the Study:
- To review common genetic events in glioma initiation and progression.
- To provide an update on genetic alterations across different glioma subtypes.
- To suggest future research directions for glioma genetic changes.
Main Methods:
- Systematic mutation analysis of glioblastomas.
- Review of genetic alterations in grade II and III gliomas.
- Identification of affected signaling pathways (receptor tyrosine kinase, TP53, pRB).
Main Results:
- Glioblastomas frequently involve the receptor tyrosine kinase, TP53, and pRB pathways.
- IDH1/2 mutations are common, but other genetic changes in lower-grade gliomas are less understood.
- TP53 mutations and BRAF gene fusions are noted in specific glioma subtypes.
Conclusions:
- Genetic alterations significantly contribute to glioma development and progression.
- Further research into the genetic landscape of all glioma subtypes is needed.
- Identifying specific genetic changes can lead to targeted therapies and improved glioma patient prognosis.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancers Originate from Somatic Mutations in a Single Cell